Umb Bank, N.A. Medpace Holdings, Inc. Transaction History

Umb Bank, N.A.

$6.3 Billion
Q3 2024

A detailed history of Umb Bank, N.A. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 271 shares of MEDP stock, worth $84,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares

271

Previous 93 191.4%

Holding current value

$84,180

Previous $38,000 136.84%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$320.58 - $457.29 $57,063 - $81,397	178 Added 191.4%	271 $90,000
Q2 2024 Jul 29, 2024	SELL	$372.0 - $424.34 $4,836 - $5,516	-13 Reduced 12.26%	93 $38,000
Q1 2024 Apr 26, 2024	SELL	$284.87 - $413.31 $50,421 - $73,155	-177 Reduced 62.54%	106 $42,000
Q3 2023 Oct 18, 2023	SELL	$233.98 - $281.67 $3,509 - $4,225	-15 Reduced 5.03%	283 $68,000
Q2 2023 Jul 25, 2023	SELL	$187.26 - $240.17 $2,996 - $3,842	-16 Reduced 5.1%	298 $71,000
Q1 2023 Apr 11, 2023	SELL	$174.31 - $239.52 $20,219 - $27,784	-116 Reduced 26.98%	314 $59,000
Q4 2022 Jan 10, 2023	SELL	$153.06 - $226.57 $12,244 - $18,125	-80 Reduced 15.69%	430 $91,000
Q3 2022 Oct 13, 2022	BUY	$145.13 - $182.49 $2,322 - $2,919	16 Added 3.24%	510 $80,000
Q2 2022 Jul 20, 2022	BUY	$130.2 - $168.03 $8,723 - $11,258	67 Added 15.69%	494 $74,000
Q1 2022 Apr 22, 2022	SELL	$138.87 - $214.31 $26,663 - $41,147	-192 Reduced 31.02%	427 $70,000
Q4 2021 Feb 09, 2022	BUY	$182.74 - $227.9 $113,116 - $141,070	619 New	619 $134,000

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account